tradingkey.logo

Co-Diagnostics Inc

CODX
0.390USD
-0.016-3.87%
Cierre 11/10, 16:00ETCotizaciones retrasadas 15 min
14.13MCap. mercado
PérdidaP/E TTM

Co-Diagnostics Inc

0.390
-0.016-3.87%

Más Datos de Co-Diagnostics Inc Compañía

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Información de Co-Diagnostics Inc

Símbolo de cotizaciónCODX
Nombre de la empresaCo-Diagnostics Inc
Fecha de salida a bolsaJul 12, 2017
Director ejecutivoMr. Dwight H. Egan
Número de empleados132
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 12
Dirección2401 S. Foothill Dr. Suite D
CiudadSALT LAKE CITY
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal84109
Teléfono18014381036
Sitio Webhttps://codiagnostics.com/
Símbolo de cotizaciónCODX
Fecha de salida a bolsaJul 12, 2017
Director ejecutivoMr. Dwight H. Egan

Ejecutivos de Co-Diagnostics Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard Abbott
Mr. Richard Abbott
President
President
618.65K
+2.30%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
272.50K
+21.56%
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
262.50K
+22.57%
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard Abbott
Mr. Richard Abbott
President
President
618.65K
+2.30%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
272.50K
+21.56%
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
262.50K
+22.57%
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
162.91K
0.00%
Rest of the world
0.00
0.00%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 20 de sep
Actualizado: sáb., 20 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Orca Capital GmbH
3.14%
The Vanguard Group, Inc.
2.84%
Private Advisory Group LLC
1.96%
Egan (Dwight H.)
1.24%
Abbott (Richard David)
1.05%
Otro
89.77%
Accionistas
Accionistas
Proporción
Orca Capital GmbH
3.14%
The Vanguard Group, Inc.
2.84%
Private Advisory Group LLC
1.96%
Egan (Dwight H.)
1.24%
Abbott (Richard David)
1.05%
Otro
89.77%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
9.34%
Individual Investor
5.04%
Investment Advisor/Hedge Fund
1.06%
Hedge Fund
0.93%
Research Firm
0.36%
Otro
83.27%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
80
7.32M
13.09%
+900.30K
2025Q2
94
8.91M
26.43%
-49.92K
2025Q1
104
8.10M
24.04%
-1.01M
2024Q4
112
7.90M
24.75%
+252.58K
2024Q3
117
6.36M
19.95%
-1.22M
2024Q2
133
6.56M
20.58%
-1.41M
2024Q1
141
5.44M
17.41%
-2.70M
2023Q4
150
5.77M
18.52%
-2.36M
2023Q3
166
5.34M
17.40%
-3.33M
2023Q2
189
5.25M
17.04%
-4.29M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Orca Capital GmbH
2.19M
4.56%
+2.19M
--
Sep 18, 2025
The Vanguard Group, Inc.
1.73M
3.6%
-44.94K
-2.53%
Jun 30, 2025
Private Advisory Group LLC
1.18M
2.45%
--
--
Jun 30, 2025
Egan (Dwight H.)
748.18K
1.55%
+111.64K
+17.54%
May 23, 2025
Abbott (Richard David)
631.47K
1.31%
+12.82K
+2.07%
May 23, 2025
Brown (Brian Lee)
599.30K
1.24%
+86.00K
+16.76%
May 23, 2025
Renaissance Technologies LLC
561.02K
1.17%
+10.70K
+1.94%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
427.44K
0.89%
-69.29K
-13.95%
Jun 30, 2025
Geode Capital Management, L.L.C.
319.99K
0.66%
-22.18K
-6.48%
Jun 30, 2025
Nelson (James B)
272.50K
0.57%
+48.33K
+21.56%
May 23, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proporción0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI